Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31232024-01-01falseThe company continued to carry out works in relation to research, development and commercialisation of drug delivery technologies and related products. The company also continued manufacturing processes and pursuit of a hybrid strategy between partnered and in-house product development.22falsetruefalse 05974331 2024-01-01 2024-12-31 05974331 2023-01-01 2023-12-31 05974331 2024-12-31 05974331 2023-12-31 05974331 2023-01-01 05974331 1 2024-01-01 2024-12-31 05974331 d:Director1 2024-01-01 2024-12-31 05974331 c:Buildings c:ShortLeaseholdAssets 2024-01-01 2024-12-31 05974331 c:Buildings c:ShortLeaseholdAssets 2024-12-31 05974331 c:Buildings c:ShortLeaseholdAssets 2023-12-31 05974331 c:FurnitureFittings 2024-01-01 2024-12-31 05974331 c:FurnitureFittings 2024-12-31 05974331 c:FurnitureFittings 2023-12-31 05974331 c:FurnitureFittings c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05974331 c:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 05974331 c:OtherPropertyPlantEquipment 2024-12-31 05974331 c:OtherPropertyPlantEquipment 2023-12-31 05974331 c:OtherPropertyPlantEquipment c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05974331 c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05974331 c:CurrentFinancialInstruments 2024-12-31 05974331 c:CurrentFinancialInstruments 2023-12-31 05974331 d:FRS102 2024-01-01 2024-12-31 05974331 d:Audited 2024-01-01 2024-12-31 05974331 d:FullAccounts 2024-01-01 2024-12-31 05974331 d:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05974331 d:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05974331 2 2024-01-01 2024-12-31 05974331 4 2024-01-01 2024-12-31 05974331 6 2024-01-01 2024-12-31 05974331 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 05974331










SISAF LTD










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
SISAF LTD
 

CONTENTS



Page
Balance Sheet
 
 
1 - 2
Notes to the Financial Statements
 
 
3 - 14


 
SISAF LTD
REGISTERED NUMBER: 05974331

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
95,389
231,751

Investments
 6 
785
785

  
96,174
232,536

Current assets
  

Stocks
  
113,434
114,792

Debtors: amounts falling due within one year
 8 
419,939
6,052,162

Cash at bank and in hand
 9 
1,284,711
3,164,756

  
1,818,084
9,331,710

Creditors: amounts falling due within one year
  
(1,054,688)
(426,483)

Net current assets
  
 
 
763,396
 
 
8,905,227

Total assets less current liabilities
  
859,570
9,137,763

Provisions for liabilities
  

Net assets excluding pension asset
  
859,570
9,137,763

Net assets
  
859,570
9,137,763


Capital and reserves
  

Called up share capital 
  
504
504

Share premium account
  
29,875,192
29,875,192

Other reserves
  
1,038,957
787,886

Profit and loss account
  
(30,055,083)
(21,525,819)

Equity attributable to owners of the parent Company
  
859,570
9,137,763

  
859,570
9,137,763


Page 1

 
SISAF LTD
REGISTERED NUMBER: 05974331

BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 24 September 2025.




Dr Roghieh Suzanne Saffie-Siebert
Director

The notes on pages 3 to 14 form part of these financial statements.

Page 2

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

SiSaf Ltd is a private Company limited by shares incorporated in England and Wales. The registered office is 8 Frederick Sanger Road, Surrey Research Park, Guildford, GU2 7YD . 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies.

The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

During the year ended 31 December 2024, the Company incurred a total comprehensive loss of £8,529,264 (2023: £3,537,657) and has accumulated losses of £30,055,083 (2023: £21,525,819) at the balance sheet date in respect of research and development activities. However, despite these losses, the directors are confident that with continued support from its investors and with potential future income streams the Company can continue for the following 12 months. The Company has net assets of £859,570 (2023: £9,137,763) at the balance sheet date and £1,284,711 (2023: £3,164,756) of bank and cash as at 31 December 2024. During the year ended 31 December 2024, the Company had net cash outflow from operating activities of £1,891,070 (2023: £3,837,062).
Since the Company’s foundation, it has been able to attract funding to support the development of the Company and fund its research and development activities. The directors have prepared detailed cashflow projections and have considered the cash burn expected in the Company for the next 12 months. Taking into consideration, additional convertible loans received post year end from their investors, other inflows of expected cash and reduced spend on external R&D, the directors are of the opinion that the Company will have sufficient funds to be able to pay its debts as they arise and continue to trade for a period of at least 12 months from the date of signing.
The directors have taken all necessary steps to ensure that the Company will continue to trade and as a result, have concluded that the financial statements should be prepared on the going concern basis.  The financial statements do not included any adjustments necessary should the going concern basis not be appropriate.

Page 3

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 4

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

  
2.5

Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
The Company expenses all patent costs through the profit and loss account.

 
2.6

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.7

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of Comprehensive Income in the same period as the related expenditure.

 
2.8

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.9

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.10

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 5

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

  
2.11

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.  
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the Company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

  
2.12

Share based payments

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted.  The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest.  A corresponding adjustment is made to equity.

 
2.13

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.14

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

 
2.15

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Short-term leasehold property
-
20%
Straight Line
Fixtures and fittings
-
20%
Straight Line
Other fixed assets
-
20%
Straight Line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 6

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.16

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Comprehensive Income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.17

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.18

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

  
2.19

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.20

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.21

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's balance sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 7

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.21
Financial instruments (continued)

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Page 8

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.21
Financial instruments (continued)

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Other financial instruments

Derivatives, including forward exchange contracts, futures contracts and interest rate swaps, are not classified as basic financial instruments. These are initially recognised at fair value on the date the derivative contract is entered into, with costs being charged to the profit or loss. They are subsequently measured at fair value with changes in the profit or loss.

Debt instruments that do not meet the conditions as set out in FRS 102 paragraph 11.9 are subsequently measured at fair value through the profit or loss. This recognition and measurement would also apply to financial instruments where the performance is evaluated on a fair value basis as with a documented risk management or investment strategy.

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Key sources of estimation uncertainty
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Useful economic lives of tangible fixed assets
The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. 

Share options valuation 
Included within other reserves are amounts relating to share options which were granted by Sisaf Ltd to key employees and consultants for the group. The Company has estimated the fair value of these options at the grant date based on an external group valuation and investment round income. 

Management charge
Management income is based on a number of assumptions by management and an estimation of costs incurred which are to be re-allocated to group companies.

Page 9

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Research & development refund 
Research and Development refund claims are estimated at the time when the financial statements are being prepared and subsequently corrected in the year in which the refund is receivable based on a best estimate of eligibility of those expenses incurred in the carrying out of R&D Activities. They are subsequently corrected, where necessary in the year in which the refund is received.

Going concern 
The financial statements have been prepared on a going concern basis. The Directors have considered
the financial position of the Company, its short-term and long-term cash requirements, liquidity position and borrowing facilities. They have also considered the Company’s business activities, income levels, current inflation pressures and other factors likely to affect its future development, performance and position. The key consideration for the directors is the availability of sufficient cash to fund the cashflow requirements of the Company as they fall due and the continued support from the investors of the Company.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







22
23


4.


Exceptional items

2024
2023
£
£


Exceptional items - write off of group balances
5,287,883
-

5,287,883
-

Included within the profit and loss account is an exceptional charge of £5,287,883 (2023: £Nil) relating to the write off of a group balance. This balance has been formally waived by the company.

Page 10

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Tangible fixed assets





Leasehold property
Fixtures and fittings
Website
Total

£
£
£
£



Cost or valuation


At 1 January 2024
744,774
1,209,553
6,155
1,960,482


Additions
-
23,442
-
23,442


Disposals
-
(37,135)
-
(37,135)



At 31 December 2024

744,774
1,195,860
6,155
1,946,789



Depreciation


At 1 January 2024
691,056
1,031,520
6,155
1,728,731


Charge for the year on owned assets
50,338
103,412
-
153,750


Disposals
-
(31,081)
-
(31,081)



At 31 December 2024

741,394
1,103,851
6,155
1,851,400



Net book value



At 31 December 2024
3,380
92,009
-
95,389



At 31 December 2023
53,718
178,033
-
231,751


6.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024
785



At 31 December 2024
785




Page 11

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

7.


Stocks

2024
2023
£
£

Raw materials and consumables
113,434
114,792

113,434
114,792


Stock is stated after a provision for impairment of £Nil (2023: £12,283). 


8.


Debtors

2024
2023
£
£


Trade debtors
211
143,326

Amounts owed by group undertakings
300
5,014,131

Other debtors
334,513
749,724

Prepayments and accrued income
84,915
144,981

419,939
6,052,162


Included in trade debtors is a bad debt provision of £172,983 (2023 : £Nil)
All trade debtors are due within the Company's normal terms. 
Amounts owed by group undertakings are unsecured, with no interest, and are payable on demand.


9.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
1,284,711
3,164,756

1,284,711
3,164,756


Page 12

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

10.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
33,482
51,005

Other taxation and social security
55,985
98,322

Other creditors
783,591
6,821

Accruals and deferred income
181,630
270,335

1,054,688
426,483


The repayment of trade creditors are within agreed supplier terms. No interest is payable on trade creditors.
Included in trade creditors is a balance of £2,500 owed to a director of the company. This balance is unsecured, interest free and repayable on demand.  
Included in other creditors is a balance of £777,841 in relation to an advancement from existing investors for the convertible loan note executed in 2025. The convertible loan note instrument was approved and created on 19 May 2025.


11.


Share-based payments

There was a loss of £251,071 (2023: £654,084 gain) in respect of share options vested in the year ended 31 December 2024. This is shown as an exceptional item in the profit and loss account.

Weighted average exercise price (pence)
2024
Number
2024
Weighted average exercise price
(pence)
2023
Number
2023

Outstanding at the beginning of the year

2.58

164,429

2.22
 
220,044
 
Granted during the year

-

-

2.64
 
83,913
 
Forfeited during the year

1.83

(52,516)

3.49
 
(13,000)
 
Exercised during the year

-

-

1.57
 
(5,000)
 
Expired during the year

-

-

1.91
 
(121,528)
 
Outstanding at the end of the year
2.94

111,913

2.58
 
164,429
 



2024
2023
£
£


Share options vested in the year
251,071
(654,084)

251,071
(654,084)

Page 13

 
SISAF LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

12.


Contingent liabilities

A contingent liability exists to repay grants should certain conditions under which they were awarded cease to be met, as stated in the Letters of Offer.


13.


Patents

The Company has expensed all patent costs through the profit and loss account, which are therefore not reflected in the balance sheet of the company. The Company has filed various patent applications in the UK and other territories. The Company is in the process of commercialising this technology and expects to see substantial revenue growth. 


14.


Related party transactions

The Company has availed of the exemption under FRS 102 in relation to the disclosure of transactions with wholly owned group companies.
Included in trade creditors is a balance of £2,500 (2023: £564) owed to a director of the company. This balance is unsecured, interest free and repayable on demand.  
Consultancy fees of £33,000 (2023: £53,069 ) were paid to a director of the company. 


15.


Post balance sheet events

SiSaf has entered into a Convertible Loan with existing investors amounting to £1,524,986. 


16.


Controlling party

Given the diversity of the shareholdings in the Company, there is no one individual considered to be the controlling party.  


17.


Auditor's liability limitation agreement

The directors, on behalf of the Company have entered into a Limited Liability Agreement on 11 December 2024, with their auditors. The auditors liability is limited to an amount which is considered fair and reasonable. This has been disclosed in line with Company's legislation.


18.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 24 September 2025 by Debbie Mullen (Senior Statutory Auditor) on behalf of AAB Group Accountants Limited.

Page 14